Form 8-K · Current Report · Filed 2024-09-09
Hims & Hers Health, Inc. Files Prospectus Supplement for Acquisition Shares
Hims & Hers Health, Inc. (Hims) has filed a prospectus supplement dated September 9, 2024, to register 976,341 shares of its Class A common stock issued to Nivagen Pharmaceuticals, Inc. in connection with Hims' acquisition of 100% of the membership interests of Seaview Enterprises LLC (d/b/a MedisourceRx) on September 5, 2024. The offering of these shares is exempt from registration under the Securities Act of 1933. A legal opinion regarding the shares is also filed as an exhibit.
- Filer
- Hims & Hers Health, Inc. HIMS · NYSE
- Filed
- Accession
- 0001104659-24-098228
- CIK
- 0001773751
- Signal
- Low impactConsumer Defensive
- Source
- Official filing on sec.gov ↗
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$13.65
Next session
+6.4%
Since filing
+103.4%
Latest close
$27.77
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HIMS reporting the same item, with the next session's move:
Exhibits (1)
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Never miss another HIMS filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.